Related references
Note: Only part of the references are listed.Erlotinib protests against LPS-induced parthanatos through inhibiting macrophage surface TLR4 expression
Qiong Xue et al.
CELL DEATH DISCOVERY (2021)
Cross-talk of pyroptosis and tumor immune landscape in lung adenocarcinoma
Xin Wang et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2021)
The Next Decade of Immune Checkpoint Therapy
Padmanee Sharma et al.
CANCER DISCOVERY (2021)
Targeting KRAS in non-small-cell lung cancer: recent progress and new approaches
M. Reck et al.
ANNALS OF ONCOLOGY (2021)
Inflammation-related pyroptosis, a novel programmed cell death pathway, and its crosstalk with immune therapy in cancer treatment
Sheng-Kai Hsu et al.
THERANOSTICS (2021)
Overexpression of GSDMC is a prognostic factor for predicting a poor outcome in lung adenocarcinoma
Jie Wei et al.
MOLECULAR MEDICINE REPORTS (2020)
Pyroptosis: A new frontier in cancer
Yuan Fang et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
NOD1 inhibits proliferation and enhances response to chemotherapy via suppressing SRC-MAPK pathway in hepatocellular carcinoma
Xiaomin Ma et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2020)
NLRC4, ASC and Caspase-1 Are Inflammasome Components That Are Mediated by P2Y2R Activation in Breast Cancer Cells
Hana Jin et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Molecular mechanisms activating the NAIP-NLRC4 inflammasome: Implications in infectious disease, autoinflammation, and cancer
Callum Kay et al.
IMMUNOLOGICAL REVIEWS (2020)
Immuno-Metabolism and Microenvironment in Cancer: Key Players for Immunotherapy
Gaia Giannone et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Ferroptosis, necroptosis, and pyroptosis in anticancer immunity
Rong Tang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
Chemotherapeutic paclitaxel and cisplatin differentially induce pyroptosis in A549 lung cancer cells via caspase-3/GSDME activation
Cheng-cheng Zhang et al.
APOPTOSIS (2019)
The role of necroptosis in cancer biology and therapy
Yitao Gong et al.
MOLECULAR CANCER (2019)
Intratumoral activation of the necroptotic pathway components RIPK1 and RIPK3 potentiates antitumor immunity
Annelise G. Snyder et al.
SCIENCE IMMUNOLOGY (2019)
Non-Small Cell Lung Cancer: Epidemiology, Screening, Diagnosis, and Treatment
Narjust Duma et al.
MAYO CLINIC PROCEEDINGS (2019)
Emerging Activators and Regulators of Inflammasomes and Pyroptosis
Yansong Xue et al.
TRENDS IN IMMUNOLOGY (2019)
Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic
T. A. Chan et al.
ANNALS OF ONCOLOGY (2019)
Paclitaxel Enhances the Innate Immunity by Promoting NLRP3 Inflammasome Activation in Macrophages
Qiong-zhen Zeng et al.
FRONTIERS IN IMMUNOLOGY (2019)
Hypoxia-inducible factor-1/interleukin-1 signaling enhances hepatoma epithelial-mesenchymal transition through macrophages in a hypoxic-inflammatory microenvironment
Jingying Zhang et al.
HEPATOLOGY (2018)
Infection of human intestinal epithelial cells by invasive bacteria activates NF-kappa B and increases ICAM-1 expression through NOD1
Woon Geon Shin et al.
KOREAN JOURNAL OF INTERNAL MEDICINE (2018)
Tumor Necrosis Factor α and Regulatory T Cells in Oncoimmunology
Benoit L. Salomon et al.
FRONTIERS IN IMMUNOLOGY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response
Peng Jiang et al.
NATURE MEDICINE (2018)
Interaction between the microbiome and TP53 in human lung cancer
K. Leigh Greathouse et al.
GENOME BIOLOGY (2018)
Lung cancer: current therapies and new targeted treatments
Fred R. Hirsch et al.
LANCET (2017)
Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade
Pornpimol Charoentong et al.
CELL REPORTS (2017)
NLRP1 Overexpression Is Correlated with the Tumorigenesis and Proliferation of Human Breast Tumor
Yuxian Wei et al.
BIOMED RESEARCH INTERNATIONAL (2017)
Inflammasome Complexes: Emerging Mechanisms and Effector Functions
Vijay A. K. Rathinam et al.
CELL (2016)
NLRC4 suppresses melanoma tumor progression independently of inflammasome activation
Ann M. Janowski et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Obesity-associated NLRC4 inflammasome activation drives breast cancer progression
Ryan Kolb et al.
NATURE COMMUNICATIONS (2016)
Epithelial NAIPs protect against colonic tumorigenesis
Ramanjaneyulu Allam et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2015)
RIPK1 and NF-κB signaling in dying cells determines cross-priming of CD8+ T cells
Nader Yatim et al.
SCIENCE (2015)
The Therapeutic Potential of Modifying Inflammasomes and NOD-Like Receptors
Francesco Di Virgilio
PHARMACOLOGICAL REVIEWS (2013)
Lung cancer and Toll-like receptors
Aldo Pinto et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Immunity, Inflammation, and Cancer
Sergei I. Grivennikov et al.
CELL (2010)
The pyroptosome: a supramolecular assembly of ASC dimers mediating inflammatory cell death via caspase-1 activation
T. Fernandes-Alnemri et al.
CELL DEATH AND DIFFERENTIATION (2007)
Share Paper
